Diagnostic performance of 124I-metaiodobenzylguanidine PET/CT in patients with pheochromocytoma
M Weber, J Schmitz, I Maric, K Pabst… - Journal of Nuclear …, 2022 - Soc Nuclear Med
123/131I-metaiodobenzylguanidine (MIBG) scintigraphy has shown a high specificity for
imaging pheochromocytoma and paraganglioma, but with low sensitivity because of low …
imaging pheochromocytoma and paraganglioma, but with low sensitivity because of low …
Low-dose 123I-metaiodobenzylguanidine diagnostic scan is inferior to 131I-metaiodobenzylguanidine posttreatment scan in detection of malignant …
D Kayano, J Taki, M Fukuoka… - Nuclear Medicine …, 2011 - journals.lww.com
Objective We assessed the lesion detectability of low-dose diagnostic 123 I-
metaiodobenzylguanidine (MIBG) whole-body scans obtained at 6 and 24 h compared with …
metaiodobenzylguanidine (MIBG) whole-body scans obtained at 6 and 24 h compared with …
Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a …
GA Wiseman, K Pacak, MS O'Dorisio… - Journal of Nuclear …, 2009 - Soc Nuclear Med
Although 123I-MIBG has been in clinical use for the imaging of pheochromocytoma for many
years, a large multicenter evaluation of this agent has never been performed. The present …
years, a large multicenter evaluation of this agent has never been performed. The present …
A comparison of the performance of 68Ga-DOTATATE PET/CT and 123I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma
JB Maurice, R Troke, Z Win, R Ramachandran… - European journal of …, 2012 - Springer
Purpose To compare the sensitivity of 123 I-metaiodobenzylguanidine (MIBG) SPECT and
68 Ga-DOTATATE PET/CT in detecting phaeochromocytomas (PCC) and paragangliomas …
68 Ga-DOTATATE PET/CT in detecting phaeochromocytomas (PCC) and paragangliomas …
Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111in-pentetreotide scintigraphy in localization of nonmetastatic and metastatic …
I Ilias, CC Chen, JA Carrasquillo… - Journal of Nuclear …, 2008 - Soc Nuclear Med
We compared functional imaging modalities including PET with 6-18F-fluorodopamine (18F-
DA) with 123I-metaiodobenzylguanidine (123I-MIBG) and somatostatin receptor …
DA) with 123I-metaiodobenzylguanidine (123I-MIBG) and somatostatin receptor …
The use of 18-fluoro-dihydroxyphenylalanine and 18-fluorodeoxyglucose positron emission tomography scanning in the assessment of metaiodobenzylguanidine …
IS Mackenzie, M Gurnell, KK Balan… - European journal of …, 2007 - academic.oup.com
Abstract 123I-Metaiodobenzylguanidine (123I-MIBG) scintigraphy scanning is commonly
used in the imaging of phaeochromocytoma (and paraganglioma) to confirm the site of …
used in the imaging of phaeochromocytoma (and paraganglioma) to confirm the site of …
MIBG and FDG PET findings in a patient with malignant pheochromocytoma: a significant discrepancy
S Ezuddin, C Fragkaki - Clinical nuclear medicine, 2005 - journals.lww.com
Radionuclide imaging has proven to be very useful when dealing with neuroendocrine
tumors and several radiotracers are currently available. One of the most commonly used and …
tumors and several radiotracers are currently available. One of the most commonly used and …
Clinical significance of quantitative 123I-MIBG SPECT/CT analysis of pheochromocytoma and paraganglioma
R Nakamoto, Y Nakamoto, T Ishimori… - Clinical Nuclear …, 2016 - journals.lww.com
Purpose This retrospective study compared the diagnostic performances of quantitative
versus visual analyses of 123 I-MIBG scintigraphy in patients with suspected …
versus visual analyses of 123 I-MIBG scintigraphy in patients with suspected …
The utility of metaiodobenzylguanidine (MIBG) scintigraphy in patients with pheochromocytoma
DY Greenblatt, Y Shenker, H Chen - Annals of Surgical Oncology, 2008 - Springer
Background Radiolabeled metaiodobenzylguanidine scintigraphy (MIBG) can be used to
image pheochromocytomas. While cross-sectional imaging techniques such as computed …
image pheochromocytomas. While cross-sectional imaging techniques such as computed …
Clinical use and utility of metaiodobenzylguanidine scintigraphy in pheochromocytoma diagnosis
I Lev, G Kelekar, A Waxman, R Yu - Endocrine Practice, 2010 - Elsevier
Objective To examine the indications for metaiodo-benzylguanidine (MIBG) scintigraphy and
to assess its performance in localizing pheochromocytoma in the post-computed …
to assess its performance in localizing pheochromocytoma in the post-computed …
Related searches
- patients with pheochromocytoma 124i metaiodobenzylguanidine
- diagnostic performance 124i metaiodobenzylguanidine
- patients with pheochromocytoma diagnostic performance
- patients with pheochromocytoma mibg scintigraphy
- diagnostic performance ga dotatate
- 131i metaiodobenzylguanidine malignant pheochromocytoma
- significant discrepancy malignant pheochromocytoma
- diagnostic scan 131i metaiodobenzylguanidine
- diagnostic scan malignant pheochromocytoma
- pheochromocytoma and paraganglioma 123i mibg
- pheochromocytoma and paraganglioma clinical significance
- metaiodobenzylguanidine scintigraphy pheochromocytoma diagnosis
- 123i metaiodobenzylguanidine metastatic pheochromocytoma
- diagnostic performance metastatic pheochromocytoma
- 123i metaiodobenzylguanidine malignant pheochromocytoma
- posttreatment scan malignant pheochromocytoma